Measurement of Hematological, Clinical Chemistry, and Infection Parameters from Hirudinized Blood Collected in Universal Blood Sampling Tubes

 

 Buy Article Permissions and Reprints

ABSTRACT

Hirudin, the anticoagulatory polypeptide of the leech Hirudo medicinalis, strongly inhibits thrombus formation by specifically interacting with thrombin. For diagnostic purposes, hirudin should be superior to other anticlotting compounds because it only minimally alters the mineral, protein, and cellular blood constituents. To test this hypothesis, hirudinized and routinely processed venous blood from 80 healthy volunteers and patients was subjected to a variety of automated blood tests. A strong correlation was found between the results of automated complete blood counts obtained from K₂-ethylenediaminetetraacetic acid (EDTA) anticoagulated and hirudinized blood (1000 antithrombin units [ATU] hirudin/ml). In addition, clinical chemistry and serological infection parameters (asparlat amintransferase [ASAT], lactate dehydrogenase [LDH], sodium, and so on, and antibodies against hepatitis B and C and human immunodeficiency virus [HIV]1/2, respectively) correlated well when measured in serum as compared with hirudinized plasma. Contrary to single clotting factors, global coagulation parameters (activated partial thromboplastin time [aPTT], prothrombin time [PT]) could not be measured in hirudinized blood. Recombinant hirudin neither interfered with immunophenotyping of mononuclear cells using FACScan analysis, nor did it alter the detection of Wilms' tumor gene expression by RT-PCR technology even at high doses (5000 ATU hirudin). Thus, a hirudin-containing blood sampling tube can be designed as a universal blood sampling tube (UBT) for testing the majority of diagnostic blood parameters.

REFERENCES

• 1 Haycraft J B. On the action of a secretion obtained from the medicinal leech on the coagulation of the blood.  Proc R Soc Lond . 1884;  36 478-487
  PubMedGoogle Scholar
• 2 Jacoby C. Über Hirudin.  Dtsch Med Wochenschr . 1904;  30 1786-1794
  PubMedGoogle Scholar
• 3 Shionoya T. Studies in experimental extracorporeal thrombosis: effects of certain anticoagulants (heparin and hirudin) on extracorporeal thrombosis and on the mechanism of thrombus formation.  J Exp Med . 1927;  49 19-26
  PubMedGoogle Scholar
• 4 Markwardt F. Die Isolierung und chemische Charakterisierung des Hirudin.  Hoppe-Seyler's Z Physiol Chem . 1957;  308 147-156
  PubMedGoogle Scholar
• 5 Harvey R P, Degryse E, Stefani L. Cloning and expression of a cDNA coding for the anticoagulant hirudin from the bloodsucking leech, Hirudo medicinalis Proc Natl Acad Sci USA .  1986;  83 1084-1088
  PubMedGoogle Scholar
• 6 Bergmann C, Dodt J, Kohler S, Fink E, Gassen H G. Chemical synthesis and expression of a gene coding for hirudin, the thrombin-specific inhibitor from the leech Hirudo medicinalis Biol Chem Hoppe Seyler .  1986;  367 731-740
  CrossrefPubMedGoogle Scholar
• 7 Bender E, Vogel R, Koller K P, Engels J. Synthesis and secretion of hirudin by Streptomyces lividans Appl Microbiol Biotechnol .  1990;  34 203-207
  PubMedGoogle Scholar
• 8 Benatti L, Scacheri E, Bishop D H, Sarmientos P. Secretion of biologically active leech hirudin from baculovirus-infected insect cells.  Gene . 1991;  101 255-260
  CrossrefPubMedGoogle Scholar
• 9 Lehman E D, Joyce J G, Bailey F J. Expression, purification and characterization of multigram amounts of a recombinant hybrid HV1-HV2 hirudin variant expressed in Saccharomyces cerevisiae Protein Expr Purif .  1993;  4 247-255
  PubMedGoogle Scholar
• 10 Weydemann U, Keup P, Piontek M. High-level secretion of hirudin by Hansenula polymorpha-authentic processing of three different preprohirudins.  Appl Microbiol Biotechnol . 1995;  44 377-385
  CrossrefPubMedGoogle Scholar
• 11 Stringer K A, Lindenfeld J A. Hirudins: antithrombin anticoagulants.  Ann Pharmocother . 1993;  26 1535-1540
  PubMedGoogle Scholar
• 12 De Filippis V, Russo I, Vindigni A. Incorporation of noncoded amino acids into the N-terminal domain 1-47 of hirudin yields a highly potent and selective thrombin inhibitor.  Protein Sci . 1999;  8 2213-2217
  PubMedGoogle Scholar
• 13 Rydel T J, Ravichandran K G, Tulinsky A. The structure of a complex of recombinant hirudin and human alpha-thrombin.  Science . 1990;  249 277-280
  CrossrefPubMedGoogle Scholar
• 14 Chang J Y, Ngai P K, Rink H, Dennis S, Schlaeppi J M. The structural elements of hirudin which bind to the fibrinogen recognition site of thrombin are exclusively located within its acidic C-terminal tail.  FEBS Lett . 1990;  261 287-290
  CrossrefPubMedGoogle Scholar
• 15 Chang J Y. Stability of hirudin, a thrombin-specific inhibitor. The structure of alkaline-inactivated hirudin.  J Biol Chem . 1991;  266 10839-10843
  PubMedGoogle Scholar
• 16 Stocker K. Hirudin for diagnostic purposes.  Haemostasis . 1991;  21 161-167
  PubMedGoogle Scholar
• 17 Griessbach U, Stürzebecher J, Markwardt F. Assay of hirudin in plasma using a chromogenic thrombin substrate.  Thromb Res . 1985;  37 347-350
  CrossrefPubMedGoogle Scholar
• 18 Menssen H D, Renkl H J, Rodeck U. Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias.  Leukemia . 1995;  9 1060-1067
  PubMedGoogle Scholar
• 19 Menssen H D, Renkl H J, Rieder H. Distinction of eosinophilic leukaemia from idiopathic hypereosinophilic syndrome by analysis of Wilms' tumour gene expression.  Br J Haematol . 1998;  101 325-334
  CrossrefPubMedGoogle Scholar
• 20 Menssen H D, Renkl H J, Rodeck U. Detection by monoclonal antibodies of the Wilms' tumor (WT1) nuclear protein in patients with acute leukemia.  Int J Cancer . 1997;  70 518-523
  CrossrefPubMedGoogle Scholar
• 21 Glantz S A. Biostatistik-Ein Fach für die Praxis. In: Heinicke A, Köpke W, eds. 4th ed Frankfurt: McGraw-Hill 1999: 241-244
  Google Scholar
• 22 Stocker K. Laboratory use of hirudin.  Semin Thromb Hemost . 1991;  17 113-121
  PubMedGoogle Scholar